Plaque imaging to refine indications for emerging lipid-lowering drugs.

about

Quantification of carotid plaque lipid content with magnetic resonance T2 mapping in patients undergoing carotid endarterectomy.The relationship of perivascular adipose tissue and atherosclerosis in the aorta and carotid arteries, determined by magnetic resonance imaging.

P2860

Q41136942-79DAEE90-C449-4969-BFEE-93A889DB8C57 Q49986999-BF6C1F3F-2171-4D59-96A6-509423DB1F5C

P2860

Plaque imaging to refine indications for emerging lipid-lowering drugs.

Item

http://www.wikidata.org/entity/Q39000038

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@en

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@nl

type

Item

label

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@en

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@nl

prefLabel

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@en

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@nl

P1476

Plaque imaging to refine indications for emerging lipid-lowering drugs.

@en

P2093

Joshua T Chai

http://www.w3.org/2001/XMLSchema#string

Mohammad Alkhalil

http://www.w3.org/2001/XMLSchema#string

Robin P Choudhury

http://www.w3.org/2001/XMLSchema#string

P2860

GPR109A and vascular inflammation

Effect of torcetrapib on the progression of coronary atherosclerosis

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Effects of torcetrapib in patients at high risk for coronary events

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Mendelian randomization of blood lipids for coronary heart disease.

P304

58-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EHJCVP/PVW034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27816944

http://www.w3.org/2001/XMLSchema#string

P932

5841877

http://www.w3.org/2001/XMLSchema#string

Plaque imaging to refine indications for emerging lipid-lowering drugs.

about

P2860

P2860

Plaque imaging to refine indications for emerging lipid-lowering drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932